Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immediate effects of an ankle assist device on gait recovery after total hip arthroplasty.

Journal of physical therapy science·2026
Same author

High-Resolution 3D Bioprinted Hydrogel Scaffolds Enable Sustained Intraperitoneal Cell Delivery.

Molecules (Basel, Switzerland)·2026
Same author

Preformulated, Shelf-Stable, Dendritic Cell-Targeting Nanogel mRNA Vaccine Delivery Platform.

Bioconjugate chemistry·2026
Same author

A 3D-Printed Scaffolded Hydrogel Microneedle Array Biosensor for Real-Time, Continuous Monitoring.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Engineered 3D-Lattice Microneedle Array Patches for Enhanced Nanovaccine Delivery to Dendritic Cells in Cancer Immunotherapy.

ACS nano·2026
Same author

Microneedle array platforms for drug delivery and biomarker sensing: From skin mechanics guided design to scalable manufacture for clinical utility.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Localized pH regulation via a dynamic proton-converting raft for gastroesophageal reflux disease.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Systems engineering of engineered live biotherapeutics: A discovery-to-translation framework for streamlining microbiome therapeutic development.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Asymmetric hydrogel with "spear-shield" properties promotes diabetic foot ulcer healing by modulating macrophage autophagy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Endogenous-metabolite-inspired polyamine-oleic acid lipids for safe mRNA delivery and PCSK9 gene editing.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Tunable rigid spikes on virus-like porous silica enable mechanistically controlled nanovaccine platforms.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Metabolic regulation-driven nanoparticles for tumor vulnerabilization and enhanced photodynamic therapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2025

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
07:41

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability

Published on: July 12, 2024

2.0K

Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle array patch delivery.

Madison M Driskill1, Ian A Coates1, Paul J Hurst2

  • 1Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|June 11, 2025
PubMed
Summary
This summary is machine-generated.

This study developed a thermostable self-amplifying RNA (saRNA) vaccine using lyophilization, reducing cold-chain dependence. The saRNA vaccine, delivered via microfluidic microarray patches, induced robust immune responses, improving vaccine accessibility.

Keywords:
Covid-19LyophilizationMicroneedleSelf-amplifying RNAVaccines

More Related Videos

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.4K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.5K

Related Experiment Videos

Last Updated: Jun 13, 2025

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
07:41

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability

Published on: July 12, 2024

2.0K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.4K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.5K

Area of Science:

  • Vaccinology
  • Biotechnology
  • Immunology

Background:

  • Messenger RNA (mRNA) vaccines are crucial for pandemics like SARS-CoV-2.
  • RNA vaccines face challenges including limited immunogenicity duration and cold-chain requirements.
  • Self-amplifying RNA (saRNA) vaccines offer sustained antigen expression and durable immunity.

Purpose of the Study:

  • To develop lyophilized formulations for SARS-CoV-2 saRNA ionizable lipid nanoparticles (LNPs).
  • To reduce the reliance of saRNA vaccines on specialized cold-chain storage.
  • To evaluate the immunogenicity and delivery of thermostable saRNA-LNPs.

Main Methods:

  • Formulation of lyophilized saRNA-LNPs for SARS-CoV-2.
  • Storage of lyophilized saRNA-LNPs above freezing temperatures for up to 15 weeks.
  • Delivery of saRNA-LNPs via intramuscular, intradermal routes, and microfluidic microarray patches (M-MAPs) in mice.

Main Results:

  • Lyophilized saRNA-LNPs induced robust immune responses in mice after storage.
  • Intradermal delivery using M-MAPs efficiently delivered saRNA-LNPs.
  • Both humoral and cellular immunity were strongly induced by the lyophilized saRNA-LNPs.

Conclusions:

  • Lyophilization creates thermostable saRNA-LNPs, reducing cold-chain dependence.
  • saRNA-LNPs delivered via M-MAPs provide a painless, self-administered vaccination method.
  • Thermostable, self-administered saRNA-LNP vaccines have the potential to enhance global vaccine coverage.